Edition:
United States

People: CVS Health Corp (CVS.N)

CVS.N on New York Stock Exchange

79.80USD
9:49am EST
Change (% chg)

$-0.73 (-0.91%)
Prev Close
$80.53
Open
$80.53
Day's High
$80.54
Day's Low
$79.70
Volume
292,207
Avg. Vol
1,748,742
52-wk High
$106.67
52-wk Low
$69.30

Moriarty, Thomas 

Mr. Thomas M. Moriarty is Executive Vice President, General Counsel, Chief Health Strategy Officer of the Company. He was General Counsel of Celgene Corporation, a global biopharmaceutical company, from May 2012 through September 2012; General Counsel and Corporate Secretary of Medco Health Solutions, Inc. (“Medco”), a pharmacy benefit management company, from March 2008 through April 2012; also President of Global Pharmaceutical Strategies of Medco from March 2011 through April 2012; Senior Vice President, Pharmaceutical Strategies and Solutions of Medco from September 2007 through March 2011.

Basic Compensation

Total Annual Compensation, USD 3,386,300
Restricted Stock Awards, USD 1,624,980
Long-Term Incentive Plans, USD --
All Other, USD 913,120
Fiscal Year Total, USD 5,924,390

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 162,192 6,514,140.00
Name Fiscal Year Total

David Dorman

--

Larry Merlo

28,943,100

David Denton

6,960,580

Lisa Bisaccia

--

Stephen Gold

--

Thomas Moriarty

5,924,390
As Of  30 Dec 2015